CXCL1 and breast carcinoma: Furthermore, the XIAOPI formula promotes chemosensitivity to Taxol treatment by inhibiting the CXCL1/HMGB1-mediated autophagy axis, diminishing survival pathways in breast cancer-resistant cells [137,234,235].